DESIGN THERAPEUTICS INC (DSGN) Stock Income Statement
NASDAQ:DSGN - US25056L1035 - Common Stock
6.45 USD
+0.34 (+5.56%)
6.45 USD
0 (0%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 74.93M | 62.00M | 78.00M | 67.59M | 35.83M | |||
| Research and Development | 55.15M | N/A | 57.06M | 48.61M | 24.78M | |||
| Selling, General, and Administrative Expenses | 19.78M | 18.00M | 21.00M | 18.98M | 11.05M | |||
| Operating Income | -74.93M | -62.00M | -78.00M | -67.59M | -35.83M | |||
| Other Income/Expense | 8.74M | 13.00M | 11.00M | 4.29M | 300.00K | |||
| Income Before Taxes | -63.49M | -50.00M | -67.00M | -63.31M | -35.53M | |||
| Net Income | -63.49M | -50.00M | -67.00M | -63.31M | -35.53M | |||
| EBITDA | -74.31M | -61.40M | -77.46M | -67.18M | -35.70M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.12 | -0.88 | -1.19 | -1.14 | -0.77 | |||
| Non GAAP EPS | -1.12 | -0.88 | -1.20 | -1.14 | -0.86 | |||
| Statistics | ||||||||
| Profit Margin | N/A | N/A | N/A | N/A | N/A | |||
| Operating Profit Margin | N/A | N/A | N/A | N/A | N/A | |||
All data in USD